ACAD NasdaqGS

ACADIA Pharmaceuticals Inc.
$21.09 1.40% Jun 12, 4:00 PM ET
Buy Zone
Fair Value
Cheaper than usualPricier than usual
12
This is not financial advice. Consult a financial advisor.

Price History

Last 12 months · Split-adjusted close

🔒 Super Investor Holdings members only

See which of 88 billion-dollar investors (Buffett, Klarman, Burry, Ackman…) own ACAD, when they bought, how much, and what they did last quarter.

Unlock with free trial →

🔒 Congress Trades members only

See every U.S. Senator and Representative who has bought or sold ACAD, with dates and trade-size brackets from STOCK Act disclosures.

Unlock with free trial →

🔒 Activist Stakes (13D) members only

See whether any activist investor — Elliott, Icahn, Starboard, ValueAct — has filed a 13D on ACAD, with the date, the stake size, and the firm's track record.

Unlock with free trial →

🔒 AI Insights + Risk Signals members only

What's working, what to watch — generated from ACAD's own filings, with overlays for recent 8-Ks, litigation, analyst downgrade waves, and short-interest crowding.

Unlock with free trial →

🔒 Financial Strength Scores members only

Piotroski F-score, Altman Z-score, Beneish M-score — see ACAD's nine-factor financial-quality fingerprint at a glance.

Unlock with free trial →

🔒 The Charts That Actually Matter members only

10 years of revenue, free cash flow, ROIC, margins, and balance-sheet trends for ACAD — the same fundamentals Buffett, Munger, and Klarman read first. Easy to scan, no MBA required.

Unlock with free trial →

See the full picture on ACADIA Pharmaceuticals Inc. (ACAD)

Super Investor holdings · Congress trades · Activist stakes · Financial-strength scores · AI Insights · Price alerts — for every U.S. stock.

Start 3-day free trial $20/mo or $200/yr. Cancel anytime.